Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Palantir wins $415 million NHS England contract to implement data system

EditorRachael Rajan
Published 11/21/2023, 04:54 PM
© Reuters.
PLTR
-
ACNN
-

LONDON - Palantir Technologies (NYSE:PLTR) Inc. and Accenture (NYSE:ACN) have formed a consortium that has been awarded a significant contract by NHS England. The $415 million agreement, announced today, tasks the consortium with implementing a data exchange system across various NHS locations over the next five years. This initiative is part of a broader effort to enhance health outcomes and reduce disparities within the healthcare system.

The Federated Data Platform (FDP), which Palantir will implement, is designed to improve interoperability across NHS trusts and Integrated Care Systems (ICSs), though it will exclude general practitioner national data. The platform will focus on several key functionalities:

  • Enhancing population health management
  • Streamlining care coordination
  • Refining supply chain processes
  • Facilitating vaccination scheduling
  • Accelerating the recuperation of elective procedures

The initial year of the contract is funded at £25.6 million, with the total value of the deal amounting to approximately £330 million over seven years. The partnership includes support from professional services firms such as PwC, NECS, and Carnall Farrar. Despite beating competitors like Oracle (NYSE:ORCL) and IBM (NYSE:IBM) for the contract, there are privacy concerns linked to Palantir's defense background and comments made by co-founder Peter Thiel criticizing the NHS.

NHS England's transformation lead, Dr. Vin Diwakar, highlighted the importance of utilizing data to optimize patient services and reduce waiting periods. Alex Karp, CEO of Palantir, has committed to providing software solutions to support these goals.

Following the allocation of the contract, a six-month phase dedicated to system migration into the new FDP framework will commence. The FDP aims not only to improve direct care and planning but also to adhere strictly to NHSE’s stringent data governance rules that prohibit research access.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The announcement has had an immediate impact on Palantir's market valuation, causing a dip to $43 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.